ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 52 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,868,000 | -2.7% | 45,237 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $1,919,000 | +1.1% | 44,228 | -0.1% | 0.00% | -20.0% |
| Q3 2020 | $1,899,000 | -3.9% | 44,258 | +4.7% | 0.01% | -16.7% |
| Q2 2020 | $1,977,000 | +163.2% | 42,290 | -23.5% | 0.01% | +100.0% |
| Q1 2020 | $751,000 | +13.3% | 55,248 | -9.4% | 0.00% | +50.0% |
| Q4 2019 | $663,000 | +5.9% | 60,971 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $626,000 | +8.7% | 60,971 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $576,000 | – | 60,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |